Cargando…
Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease
BACKGROUND: Approximately 30% of patients who are treated with proton pump inhibitors (PPIs) for gastroesophageal reflux disease (GERD) experience persistent symptoms. No prokinetic agent regiments are useful for symptom relief. AIMS: This study was conducted to examine the effect of adding acotiami...
Autores principales: | Yamashita, Hiroshi, Okada, Akihiko, Naora, Kohji, Hongoh, Masafumi, Kinoshita, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394577/ https://www.ncbi.nlm.nih.gov/pubmed/30465175 http://dx.doi.org/10.1007/s10620-018-5377-9 |
Ejemplares similares
-
Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers
por: Ishimura, Norihisa, et al.
Publicado: (2015) -
Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
por: Mikami, Hironobu, et al.
Publicado: (2018) -
Effects of Rikkunshito (TJ-43) on Esophageal Motor Function and Gastroesophageal Reflux
por: Morita, Terumi, et al.
Publicado: (2012) -
Profile of acotiamide in the treatment of functional dyspepsia
por: Ueda, Masahiro, et al.
Publicado: (2016) -
A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia
por: Matsueda, Kei, et al.
Publicado: (2011)